L9LS MAb in Malian Infants
Clinical trial NCT06461026 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06461026
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-19
- Primary completion
- 2025-06-27
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.